Autres ressources ENHERTU®

Podcasts

Trastuzumab Deruxtecan ILD by Prof. Jerusalem & Prof. Duhoux

Trastuzumab Deruxtecan Other Adverse Effects  by Prof. Jerusalem, Prof. Duhoux & Dr Aftimos

Trastuzumab Deruxtecan Nausea and vomiting by Prof. Jerusalem & Dr Aftimos

BJMO Highlights of 2022 SABCS by Dr Aftimos

Video

Trastuzumab Deruxtecan Nausea  and vomiting by Prof. Jerusalem & Dr Aftimos

Trastuzumab Deruxtecan ILD by Prof. Jerusalem & Prof. Duhoux

Trastuzumab Deruxtecan Other Adverse Effects  by Prof. Jerusalem, Prof. Duhoux & Dr Aftimos

Dr. Duhem answers questions on ADC sequencing, practical aspects when treating with ADCs and how to optimize treatment with ENHERTU®

Documents

Optimizing treatment management of Trastuzumab Deruxtecan by Prof Jerusalem & Prof. Wildiers 2022 BJMO

Belgian clinical guidelines for HER2-postivie advanced breast cancer 2022 BJMO

Article Cancer du sein métastatique HER2+ : le T-Dxd fortement recommandé par l'ESMO et la BSMO par Prof. Duhoux

ILD & Pneumonitis management Dr Duhoux Dr Naert

Nausea & vomiting management Dr Aftimos Prof Wildiers